Condition (MeSH)
Aspergillosis, Allergic Bronchopulmonary
ClinicalTrials.gov lists 42 trials for Aspergillosis, Allergic Bronchopulmonary or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
1 more section with rows
42 of the 42 trials are tagged with Aspergillosis, Allergic Bronchopulmonary itself; the rest are tagged with a narrower condition beneath it.
When did Aspergillosis, Allergic Bronchopulmonary trials start? (19)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 6
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 6 |
| 2024 | 2 |
| 2023 | 2 |
| 2022 | 3 |
| 2021 | 4 |
| 2020 | 3 |
| 2019 | 2 |
| 2017 | 2 |
| 2016 | 2 |
Showing 10 of 19 earlier years.
No forecast is made for this condition: it averages 3.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Aspergillosis, Allergic Bronchopulmonary trials in? (9)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 1/2 | 1 |
| Phase 2 | 5 |
| Phase 2/3 | 7 |
| Phase 3 | 3 |
| Phase 4 | 2 |
| Not applicable | 7 |
| Observational | 15 |
| Expanded access | 1 |
How many Aspergillosis, Allergic Bronchopulmonary trials are recruiting? (8)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 10 |
| Active, not recruiting | 1 |
| Completed | 20 |
| Terminated | 4 |
Showing 5 of 8 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Aspergillosis, Allergic Bronchopulmonary trials? (6)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| GlaxoSmithKline | 2 |
| Novartis Pharmaceuticals | 2 |
| Pulmatrix Inc. | 2 |
| First Affiliated Hospital of Ningbo University | 1 |
| Regeneron Pharmaceuticals | 1 |
Showing 5 of 6 sponsors.
Which drugs are being tested for Aspergillosis, Allergic Bronchopulmonary? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Itraconazole | 7 |
| PREDNISOLONE | 3 |
Interventions as named in the registry (13)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Glucocorticoids | 4 |
| Voriconazole 1% | 2 |
| Drug: Omalizumab | 2 |
| Inhaled budesonide | 1 |
| Iron Therapy | 1 |
Showing 5 of 13 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Aspergillosis, Allergic Bronchopulmonary trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Pneumonia | 173 | 4 |
| Arteriovenous fistula thrombosis | 93 | 1 |
| Fluid overload | 87 | 1 |
| Sepsis | 71 | 2 |
| Anaemia | 69 | 2 |
Showing 5 of 10 adverse events.
Which publications cover Aspergillosis, Allergic Bronchopulmonary? (49)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma. | Chest | 2024 | Yes |
| Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial. | The European respiratory journal | 2022 | Yes |
| COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy. | The European respiratory journal | 2021 | Yes |
| Evaluation of an Aspergillus IgG/IgM lateral flow assay for serodiagnosis of fungal asthma in Uganda. | PloS one | 2021 | Yes |
| The Clinical Implications of Aspergillus Fumigatus Sensitization in Difficult-To-Treat Asthma Patients. | The journal of allergy and clinical immunology. In practice | 2021 | Yes |
Showing 5 of 49 publications.
Prevalence (3)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Allergic bronchopulmonary aspergillosis | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Allergic bronchopulmonary aspergillosis | Point prevalence | Unknown | Worldwide | Not stated | Unspecified |
| Allergic bronchopulmonary aspergillosis | Point prevalence | Unknown | Worldwide | Not stated | Exact |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Allergic bronchopulmonary aspergillosis | 1164 | Exact | Orphadata Science knowledge files, Product 1 |
| Allergic bronchopulmonary aspergillosis | 1164 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: sub-conditions in mesh.